The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business, for $114,000 to provide next generation sequencing on 177 genes. The contract has a completion date of November 1, 2023. Genomic Testing Cooperative is a tumor profiling laboratory that offers DNA and RNA testing for cancer biomarkers and has previously...
This is a $85,500.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract is for providing next-generation genomic sequence test services to support biomedical research efforts, with a focus on hematology-related research. The contract does not have a set-aside designation and is scheduled...
This is a firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract, valued at $19,500.00, requires the contractor to provide hematology panel testing services, specifically sequencing somatic mutations in bone marrow samples, in order to provide guidance for the treatment and diagnosis of...
The National Heart, Lung and Blood Institute of the National Institutes of Health, within the Department of Health and Human Services, awarded a $90,000 firm fixed price purchase order to Genomic Testing Cooperative LCA Genomic Testing Cooperative Division. The prime contractor will provide detection of somatic gene mutations in patients to the agency over a one year period of performance in Bethesda, Maryland. This contract has a total small business set aside designation. The award supports...
This is a $45,000.00 firm-fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Heart, Lung and Blood Institute (NHLBI) to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business. The contract is for the provision of a 177-gene Hematology Panel, in support of NHLBI's biomedical research efforts. The contract does not have a set-aside designation. Genomic Testing Cooperative, LCA has held...
Genomic Testing Cooperative, LCA has been awarded a firm fixed price purchase order valued at fifteen thousand dollars by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract calls for the contractor to provide sequencing of bone marrow samples in order to aid patients' diagnosis and treatment guidance for diseases, as described in solicitation 24-007899. No set aside designation was applied to this award. Performance...
This federal contract award, valued at $28,500.00, was issued by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA (GTC), a self-certified small disadvantaged business. The contract is for the detection of somatic gene mutations in patients, which supports the NHLBI's biomedical research efforts. GTC has a history of providing genomic sequencing and testing services to the NHLBI, with previous contract...
The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) awarded a firm-fixed-price purchase order contract to Genomic Testing Cooperative, LCA (GTC), a self-certified small disadvantaged business, for the provision of a 177-gene Hematology Panel. The $90,000.00 contract has an ultimate completion date of December 8, 2025 and supports the NHLBI's biomedical research initiatives, contributing to advancements in the understanding and treatment of various...
<p>The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $249,648.00 firm fixed price purchase order to Medical Neurogenetics, LLC, a for-profit organization, for clinical genetic testing services. The contract has a completion date of November 2, 2023 and does not have a set-aside designation. The place of performance is Bethesda, Maryland.</p>
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Genedx, LLC, a wholly owned subsidiary of Opko Health, Inc. The contract provides laboratory testing services, including genetic testing and diagnostic services, to support research and clinical programs at the NIH. The contract has a ceiling value of $5,775 and a period of performance through May 22, 2023. The contract was awarded on...